Perioperative management of von Willebrand patients at the time of implant placement: Case report

Abstract

Abstract In the management of patients with type 1 von Willebrand disease, supplementation with Con Facto F® as well as hemodynamic stabilization with appropriate analgesia and sedation may be important to reduce the risk of bleeding.

Keywords

• a hemostatic factor
• factor VIII concentrate (Confact F®)
• von Willebrand disease